- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 15.98M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $90.07M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $80.41M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5.63M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $5.63M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $19.76M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $18.77M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $93.86M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $101.75M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $216.54M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $216.28M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $272M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $273.05M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $410.97M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $415.13M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.45M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $2.33M |
| Capex | Q1 2025 · Mar 31, 2024 | $675K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $9.45M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $200.82M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $197.64M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.24 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.24 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $48.94M |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.91M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $55.32M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $83.53M |
| Revenue | Q1 2025 · Mar 31, 2024 | $138.84M |